1. The role of imaging in clinical prostate cancer - Overview of Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Dynamic Contrast-Enhanced MRI (DCE-MRI), MR spectroscopic Imaging (MRSI), Photoacoustic Imaging (PAI).- 2. Automated quantitative cell and tissue imaging technologies.- 3. Diagnostic and early prostate cancer imaging; imaging of advanced prostate cancer.- 4. Emerging radiation techniques.
- 5. Radiation therapy and partial prostate irradiation.- 6. Prostate cancer screening: radiology perspectives.- 7. Preclinical imaging of metastasis and dormancy: clinical implications.- 8. Utility of CT in the management of prostate cancer.
- 9. Nanotechnology, cancer diagnosis and treatments.- 10. Imaging approaches to distinguish lethal from non-lethal disease.- 11. Photoacoustic imaging.- 12. Molecular and anatomical imaging in drug development.
- 13. Molecular imaging modalities including CT, PET, SPECT, MRI, MRS, Hyperpolarized MRI, Ultrasound, X-ray computed tomography, Fusion Imaging (Molecular/Anatomic).- 14. Functional imaging (PET vs. SPECT).- 15. Optical bioluminescence molecular imaging.- 16.
Therapeutic radiopharmaceutical translational research imaging.- 17. Accuracy of magnetic resonance imaging for local staging of prostate cancer: diagnostic meta-analysis.- 18. Adjuvant radiotherapy for pathologically advanced prostate cancer: randomized clinical trial.- 19. High-intensity focused ultrasound (HIFU) with histopathological analysis.- 20.
Image-directed, tissue-preserving focal therapy of prostate cancer with a novel deformable magnetic resonance-ultrasound (MR-US) registration system.- 21. Focal therapy for localized unifocal and multifocal prostate cancer.- 22. Focal cryotherapy for clinically unilateral, low to intermediate risk prostate cancer.- 23. Impact of obesity on clinico-pathologic outcomes after robot-assisted laparoscopic prostatectomy.- 24.
Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy.